3 December 2020

APLAR COVID-19 Pharmaceuticals Public Health

Most big pharma firms broke law in last decade: study

4 November 2020

Analgesics Conditions Pharmacy Guild of Australia

COVID or giant cell arteritis: how to spot the difference

4 November 2020

Conditions

Attack of the phages

22 September 2020

Conditions

IL-17 inhibitor appears safe and effective for nr-axSpA

27 August 2020

Global Health

Bioterrorism: how afraid should we really be?

27 August 2020

Conditions

Software update switches all brand names to generics

28 July 2020

Pain

Pain campaign helps patients both manage and talk about it

15 July 2020

Conditions Technology

TGA approves Ixekizumab for AS

24 June 2020

APLAR Conditions

Flu is dead, long live flu

5 June 2020

Conditions COVID-19

COVID-19’s silver lining for our flu season

5 June 2020

Analgesics Conditions Spondyloarthritis

Opioid use for rheuma pain rising, warn European experts

21 May 2020

Backstage tour of EULAR virtual

7 May 2020

Conditions Lupus

Promise for ankylosing spondylitis drug that targets IL-17A and IL-17F

8 April 2020

Registrar’s handbook plugs training gap for private practice

8 April 2020

EULAR to host virtual conference

26 March 2020

APLAR Conditions

Rheuma drugs co-opted in fight against COVID-19